Genetic Evolution during the development of an attenuated EIAV vaccine

Area of Science:

• Virology
• Molecular Biology
• Vaccine Development

Background:

• The equine infectious anemia virus (EIAV) vaccine is a large-scale, effective attenuated lentiviral vaccine used in China.
• Its development involved serial passaging of a virulent strain in various hosts and cell cultures.
• Understanding the genomic evolution during attenuation is crucial for lentiviral vaccine design.

Purpose of the Study:

• To investigate the genomic alterations of the EIAV vaccine strain during its development.
• To elucidate the molecular basis for the observed changes in pathogenicity and immunogenicity.

Main Methods:

• Systematic genomic sequencing of EIAV strains at different passage levels.
• Comparative analysis of genetic distance and mutation accumulation.
• Statistical analysis of mutation frequencies in virulent versus attenuated strains.

Main Results:

• Genetic distance increased with passaging, with the Env gene showing a distinct evolutionary pattern.
• Stable mutations accumulated across multiple genes during adaptation to cell culture.
• Virus adaptation correlated with decreased pathogenicity and increased immunogenicity.
• Significant differences in mutation frequencies were observed between in vivo/ex vivo and virulent/attenuated strains.

Conclusions:

• EIAV evolution during vaccine development is driven by mutation accumulation under selective pressure.
• These findings enhance understanding of the molecular mechanisms underlying lentivirus pathogenicity and immunogenicity.
• The study provides a molecular basis for lentiviral vaccine attenuation and adaptation.